New antibiofilm strategies for the management of nontuberculous mycobacteria diseases.
Autor: | Cano-Fernández M; Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain., Esteban J; Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain.; CIBERINFEC-CIBER de Enfermedades Infecciosas, Madrid, Spain. |
---|---|
Jazyk: | angličtina |
Zdroj: | Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Oct; Vol. 25 (15), pp. 2035-2046. Date of Electronic Publication: 2024 Oct 09. |
DOI: | 10.1080/14656566.2024.2412250 |
Abstrakt: | Introduction: Nontuberculous mycobacteria (NTM) represent a group of microorganisms comprising more than 190 species. NTM infections have increased recently, and their treatment is a major challenge because to their resistance to conventional treatments. This review focuses on innovative strategies aimed at eradicating NTM biofilms, a critical factor in their resistance. Important areas addressed include biofilm formation mechanisms, current therapeutic challenges, and novel treatment approaches. The main objective is to compile and analyze information on these emerging strategies, identifying pivotal research directions and recent advancements. Areas Covered: A review of the scientific literature was conducted to identify emerging novel therapies for the treatment of NTM infections and to explore potential synergies with existing treatments. Expert Opinion: Experts highlights a limited understanding of optimal treatment regimens, often supported by insufficient scientific evidence. Current therapies are typically prolonged, involve multiple antibiotics with adverse effects, and frequently do not achieve patient cure. Certain species are even considered virtually impossible to eradicate. A thorough understanding of these new approaches is imperative for improving patients outcomes. This review provides a robust foundation for developing of more effective antibacterial strategies, which are essential because of the increasing incidence of NTM infections and the limitations of existing therapies. |
Databáze: | MEDLINE |
Externí odkaz: |